Cargando…
Selective BD2 Inhibitor Exerts Anti-Fibrotic Effects via BRD4/FoxM1/Plk1 Axis in Orbital Fibroblasts From Patients With Thyroid Eye Disease
PURPOSE: We investigated the therapeutic potential of ABBV744, a bromodomain and extra-terminal (BET) inhibitor with selectivity for the second bromodomain (BD2) in thyroid eye disease (TED). The anti-fibrotic effects of ABBV744 and its underlying mechanism were explored in cultured orbital fibrobla...
Autores principales: | Xie, Yanyan, Pan, Yuan, Chen, Qian, Chen, Yuxi, Chen, Guanyu, Wang, Mei, Zeng, Peng, Li, Zhuang, Li, Zuoyi, Wang, Sha, Yang, Huasheng, Liang, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246756/ https://www.ncbi.nlm.nih.gov/pubmed/37272763 http://dx.doi.org/10.1167/iovs.64.7.9 |
Ejemplares similares
-
Plk1 Regulates the Repressor Function of FoxM1b by inhibiting its Interaction with the Retinoblastoma Protein
por: Mukhopadhyay, Nishit K., et al.
Publicado: (2017) -
Author Correction: Plk1 Regulates the Repressor Function of FoxM1b by inhibiting its Interaction with the Retinoblastoma Protein
por: Mukhopadhyay, Nishit K., et al.
Publicado: (2018) -
CDI Exerts Anti-Tumor Effects by Blocking the FoxM1-DNA Interaction
por: Jang, Woo Dae, et al.
Publicado: (2022) -
High-risk histological subtype-related FAM83A hijacked FOXM1 transcriptional regulation to promote malignant progression in lung adenocarcinoma
por: Fei, Wei, et al.
Publicado: (2023) -
The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma
por: Dibb, M, et al.
Publicado: (2012)